본문 바로가기
KERD
논문KCI 등재

Role of certain nutritional supplements and biological regulators in the epilepsy

Mohammad Asif
셀메드 세포교정의약학회 (Cellmed Orthocellular Medicine and Pharmaceutical Association)|2013.11|셀메드 (CELLMED)|제3권 제4호|pp. 29-29

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

foodhormonesseizurenutrientepilepsyvitamins
주제분류의학일반

초록

Certain dietary contents, biological supplements might influence the occurrence or treatment of epilepsy. Some studies have found that the supplementation with individual nutrients reduced seizure frequency or improved other aspects of health in patients with epilepsy. Potentially beneficial dietary interventions include treating blood glucose dysregulations. Identifying and avoiding allergenic foods, and avoiding suspected triggering agents such as alcohol, aspartame, and monosodium glutamate. The Atkins diet (very low in carbohydrates) is a less restrictive type diet that may be effective in some cases. Nutrients that may reduce seizure frequency include vitamin B6, magnesium, vitamin E, manganese, taurine, dimethylglycine, and omega-3 fatty acids. Administration of thiamine may improve cognitive function in patients with epilepsy. Supplementation with folic acid, vitamin B6, biotin, vitamin D, and L-carnitine may be needed to prevent or treat deficiencies resulting from the use of anticonvulsant drugs. Vitamin K1 has been recommended near the end of pregnancy for women taking anticonvulsants. Melatonin may reduce seizure frequency in some cases, and progesterone may be useful for women with cyclic exacerbations of seizures. In most cases, nutritional therapy is not a substitute for anticonvulsant medications. However, in selected cases, depending on the effectiveness of the interventions, dosage reductions or discontinuation of medications may be possible. However, nutrient supplementation may be necessary to prevent or reverse the effects of certain deficiencies that frequently result from the use of antiepileptic drugs.

Abstract

Certain dietary contents, biological supplements might influence the occurrence or treatment of epilepsy. Some studies have found that the supplementation with individual nutrients reduced seizure frequency or improved other aspects of health in patients with epilepsy. Potentially beneficial dietary interventions include treating blood glucose dysregulations. Identifying and avoiding allergenic foods, and avoiding suspected triggering agents such as alcohol, aspartame, and monosodium glutamate. The Atkins diet (very low in carbohydrates) is a less restrictive type diet that may be effective in some cases. Nutrients that may reduce seizure frequency include vitamin B6, magnesium, vitamin E, manganese, taurine, dimethylglycine, and omega-3 fatty acids. Administration of thiamine may improve cognitive function in patients with epilepsy. Supplementation with folic acid, vitamin B6, biotin, vitamin D, and L-carnitine may be needed to prevent or treat deficiencies resulting from the use of anticonvulsant drugs. Vitamin K1 has been recommended near the end of pregnancy for women taking anticonvulsants. Melatonin may reduce seizure frequency in some cases, and progesterone may be useful for women with cyclic exacerbations of seizures. In most cases, nutritional therapy is not a substitute for anticonvulsant medications. However, in selected cases, depending on the effectiveness of the interventions, dosage reductions or discontinuation of medications may be possible. However, nutrient supplementation may be necessary to prevent or reverse the effects of certain deficiencies that frequently result from the use of antiepileptic drugs.

참고문헌 (142)

  1. Afzal S, "A study of serum and cerebrospinal fluid magnesium in convulsive disorders", J Assoc Physicians, 33, pp.161~163 (1985)
  2. Anderson GD, "Pharmacogenetics and enzyme induction", inhibition properties of antiepileptic drugs, 2004, pp.63, S3~S8
  3. Asadi-Pooya AA, "Do patients with epilepsy believe they need specific dietary restrictions?", Epilepsy Behav, 5, pp.945~948 (2004)
  4. Asadi-Pooya AA, "Allergy and idiopathic generalized epilepsy: a case-control study", J Pediatr Neurol, 5, pp.231~232 (2007)
  5. Asadi-Pooya AA, "Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine", Epilepsy Behav, 8, pp.228~231 (2006)
  6. Asadi-Pooya AA, "What do nurses and physicians think about the need for specific dietary restrictions in the patients with epilepsy?", Epilepsy Behav, 6, pp.604~606 (2005)
  7. Asadi-Pooya AA, "Nutritional supplements, foods, and epilepsy: Is there a relationship?", Epilepsia, 49, pp.1819~1827 (2008)
  8. Asadi-Pooya AA, "Do foods precipitate seizures?. A cross-cultural comparison", Epilepsy Behav, 11, pp.450~453 (2007)
  9. Asadi-Pooya AA, "Risk factors for carbamazepine-induced leucopenia in children and adolescents", J Pediatr Neurol, 3, pp.233~235 (2005)
  10. Auer RN, "Can eliminating monosodium glutamate from the diet affect Lennox-Gastaut syndrome?", J Am Diet Assoc, 98, pp.857~ (1998)
  11. Bankier A, "Pyridoxine dependent seizures-a wider clinical spectrum", Arch Dis Child, 58, pp.415~418 (1983)
  12. Barbeau A, "Zinc, taurine, and epilepsy", Arch Neurol, 30, pp.52~58 (1974)
  13. Bennett CL, "Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures", Neurogenetics, 6, pp.143~149 (2005)
  14. Bergamini L, "First clinical experience on the antiepileptic action of taurine", Eur Neurol, 11, pp.261~269 (1974)
  15. Berry-Kravis E, "Bruising and the ketogenic diet: evidence for dietinduced changes in platelet function", Ann Neurol, 49, pp.98~103 (2001)
  16. Bhagavan HN, "Monosodium glutamate induces convulsive disorders in rats", Nature, 232, pp.275~276 (1971)
  17. Bonilha L, "Heavy coffee drinking and epilepsy", Seizure, 13, pp.284~285 (2004)
  18. Borges LF, "Effect of magnesium on epileptic foci", Epilepsia, 19, pp.81~91 (1978)
  19. Botez MI, "Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale", Epilepsy Res, 16, pp.157~163 (1993)
  20. Brown RS, "The administration of folic acid to institutionalized epileptic adults with phenytoininduced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study", Oral Surg Oral Med Oral Pathol, 71, pp.565~568 (1991)
  21. Camfield PR, "Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study", Neurology, 42, pp.1000~1003 (1992)
  22. Carl GF, "Association of low blood manganese concentrations with epilepsy", Neurology, 36, pp.1584~1587 (1986)
  23. Castaneda GY, "Asthma and epilepsy: are they related? A retrospective study", J Child Neurol, 13, pp.283~285 (1988)
  24. Ch'ien LT, "Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics", Am J Clin Nutr, 28, pp.51~58 (1975)
  25. Chou DT, "Unit activity in medial thalamus: comparative effects of caffeine an amphetamine", J Pharmacol Exp Ther, 213, pp.580~585 (1980)
  26. Christiansen C, "Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial", Br Med J, 4, pp.695~701 (1973)
  27. Christiansen C, ""Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study", Br Med J, 2, pp.258~259 (1974)
  28. Clarke TA, "Pyridoxine-dependent seizures requiring high doses of pyridoxine for control", Am J Dis Child, 133, pp.963~965 (1979)
  29. Coker SB, "Postneonatal vitamin B6-dependent epilepsy", Pediatrics, 90, pp.221~223 (1992)
  30. Cornelissen M, "Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency", Am J Obstet Gynecol, 168, pp.884~888 (1993)
  31. Crayton JW, "Epilepsy precipitated by food sensitivity: report of a case with double-blind placebo-controlled assessment", Clin Electroencephalogr, 12, pp.192~198 (1981)
  32. Cronin CC, "Celiac disease and epilepsy", QJM, 91, pp.303~308 (1998)
  33. Crowell GF, "Pyridoxine-dependent seizures", Am Fam Physician, 27, pp.183~187 (1983)
  34. Cunningham AS, "Allergy, immunodeficiency, and epilepsy", Lancet, 2, pp.975~ (1975)
  35. Davis RE, "Serum pyridoxal, folate, and vitamin B12 levels in institutionalized epileptics", Epilepsia, 16, pp.463~468 (1975)
  36. De Lecea A, "Serological screening for non-overt coeliac disease in children of short stature", Acta Paediatr Suppl, 412, pp.54~55 (1996)
  37. De Vivo DC, "L-carnitine supplementation in childhood epilepsy: current perspectives", Epilepsia, 39, pp.1216~1225 (1998)
  38. Deb S, "Folate metabolism and problem behaviour in mentally handicapped epileptics", J Ment Defic Res, 31, pp.163~168 (1987)
  39. Djukic A, "Folate-responsive neurologic diseases", Pediatr Neurol, 37, pp.387~397 (2007)
  40. Dupont CL, "Blood manganese levels in children with convulsive disorder", Biochem Med, 33, pp.246~255 (1985)
  41. Edelstein SF, "Management of intractable childhood seizures using the non-MCT oil ketogenic diet in 20 patients", J Am Diet Assoc, 96, pp.1181~1182 (1996)
  42. Egger J, "Oligoantigenic diet treatment of children with epilepsy and migraine", J Pediatr, 114, pp.51~58 (1989)
  43. Frediani T, "Allergy and childhood epilepsy: a close relationship?", Acta Neurol Scand, 104, pp.349~352 (2001)
  44. Freed WJ, "Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine", Pharmacol Biochem Behav, 22, pp.641~643 (1985)
  45. Furlanut M, "Effects of folic acid on phenytoin kinetics in healthy subjects", Clin Pharmacol Ther, 24, pp.294~297 (1978)
  46. Gaby AR, "Magnesium" (1994), Keats Publishing
  47. Gaby AR, "Natural Approaches to Epilepsy", Altern Med Rev, 12, pp.9~24 (2007)
  48. Gaby AR, "The Doctor's Guide to Vitamin B6" (1984), Rodale Press
  49. Gallagher BB, "Seizure threshold and excess dietary amino acids", Neurology, 18, pp.208~212 (1968)
  50. Garg SK, "Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy", Clin Pharmacol Ther, 64, pp.286~288 (1998)
  51. Gasch AT, "Use of the traditional ketogenic diet for treatment of intractable epilepsy", J Am Diet Assoc, 90, pp.1433~1434 (1990)
  52. Gascon G, "N,N dimethylglycine and epilepsy", Epilepsia, 30, pp.90~93 (1989)
  53. Gibberd FB, "The influence of folic acid on the frequency of epileptic attacks", Eur J Clin Pharmacol, 19, pp.57~60 (1981)
  54. Gissel T, "Adverse effects of antiepileptic drugs on bone mineral density in children", Expert Opin Drug Saf, 6, pp.267~278 (2007)
  55. Goasduff T, "Induction of liver and kidney CYP1A1", 1A2 by caffeine in rat, 1996, pp.52, 1915~1919
  56. Gobbi G, "Celiac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy", Lancet, 340, pp.439~443 (1992)
  57. Goodman HO, "Taurine transport in epilepsy", Clin Chem, 26, pp.414~419 (1980)
  58. Gordon N, "Medium-chain triglycerides in a ketogenic diet", Dev Med Child Neurol, 19, pp.535~538 (1977)
  59. Gospe SM Jr, "Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment", Curr Opin Neurol, 19, pp.148~153 (2006)
  60. Goutieres F, "Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants", Ann Neurol, 17, pp.117~120 (1985)
  61. Grant ECG, "Epilepsy and manganese", Lancet, 363, pp.572~ (2004)
  62. Grant RH, "Folic acid in folate-deficient patients with epilepsy", Br Med J, 4, pp.644~648 (1970)
  63. Guidolin L, "Worsening in seizure frequency and severity in relation to folic acid administration", Eur J Neurol, 5, pp.301~303 (1998)
  64. Haidukewych D, "N,N-dimethylglycine shows no anticonvulsant potential", Ann Neurol, 15, pp.405~ (1984)
  65. Hansson O, "Letter: Pyridoxine and serum concentration of phenytoin and phenobarbitone", Lancet, 1, pp.256~ (1976)
  66. Hemingway C, "The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively", Pediatrics, 108, pp.898~905 (2001)
  67. Hernandez MA, "Epilepsy, cerebral calcifications and clinical or subclinical celiac disease. Course and follow up with gluten-free diet", Seizure, 7, pp.49~54 (1998)
  68. Herzog AG, "Progesterone therapy in women with complex partial and secondary generalized seizures", Neurology, 45, pp.1660~1662 (1995)
  69. Hewitt NJ, "Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations", Xenobiotica, 37, pp.1196~1224 (2007)
  70. Hidaka M, "Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity", Drug Metab Dispos, 32, pp.581~583 (2004)
  71. Higashi A, "Serum vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants", Pediatr Pharmacol (New York), 1, pp.129~134 (1980)
  72. Hiilesmaa VK, "Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome", Br Med J (Clin Res ed), 287, pp.577~579 (1983)
  73. Holman CP, "A trial of evening primrose oil in the treatment of chronic schizophrenia", J Orthomolecular Psychiatry, 12, pp.302~304 (1983)
  74. Hom AC, "Efficacy of D-alpha tocopherol acetate as adjunctive antiepileptic agent in patients with refractory epilepsy and profound developmental disability: a prospective, randomized, double-blind, placebo-controlled trial", Epilepsia, 32, pp.S62~ (1991)
  75. Huttenlocher PR, "Mediumchain triglycerides as a therapy for intractable childhood epilepsy", Neurology, 21, pp.1097~1103 (1971)
  76. Johnson GM, "Powdered goat's milk: pyridoxine deficiency and status epilepticus", Clin Pediatr (Phila), 21, pp.494~495 (1982)
  77. Jones C, "Melatonin and epilepsy", Arch Dis Child, 90, pp.1203~ (2005)
  78. Joshi S, "Biotinidase deficiency: a treatable genetic disorder in the Saudi population", East Mediterr Health J, 5, pp.1213~1217 (1999)
  79. Kaufman KR, "Caffeinated beverages and decreased seizure control", Seizure, 12, pp.519~521 (2003)
  80. Kerr BM, "Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation", Biochem Pharmacol, 47, pp.1969~1979 (1994)
  81. Keyser A, "Epileptic manifestations and vitamin B1 deficiency", Eur Neurol, 31, pp.121~125 (1991)
  82. Kim H, "Inhibitory effects of fruit juices on CYP3A activity", Drug Metab Dispos, 34, pp.521~523 (2006)
  83. Kossoff EH, "Efficacy of the Atkins diet as therapy for intractable epilepsy", Neurology, 61, pp.1789~1791 (2003)
  84. Krause KH, "Impaired biotin status in anticonvulsant therapy", Ann Neurol, 12, pp.485~486 (1982)
  85. Kroll JS, "Pyridoxine for neonatal seizures: an unexpected danger", Dev Med Child Neurol, 27, pp.377~379 (1985)
  86. Kumandas S, "Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3", J Pediatr Endocrinol Metab, 19, pp.529~534 (2006)
  87. Kuo MF, "Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine", Pediatr Neurol, 26, pp.146~147 (2002)
  88. Labate A, "Silent celiac disease in patients with childhood localization-related epilepsies", Epilepsia, 42, pp.1153~1155 (2001)
  89. Lauritzen I, "Polyunsaturated fatty acids are potent neuroprotectors", EMBO J, 19, pp.1784~1793 (2000)
  90. Levy SL, "An evaluation of the anticonvulsant effects of vitamin E", Epilepsy Res, 6, pp.12~17 (1990)
  91. Mantovani J, "Effects of taurine on seizures and growth hormone release in epileptic patients", Arch Neurol, 36, pp.672~674 (1979)
  92. Mattson RH, "Folate therapy in epilepsy. A controlled study", Arch Neurol, 29, pp.78~81 (1973)
  93. Mikati MA, "Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up", Electroencephalogr Clin Neurophysiol, 78, pp.215~221 (1991)
  94. Mintzer S, "Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine", Epilepsia, 47, pp.510~515 (2006)
  95. Miwa H, "Generalized convulsions after consuming a large amount of Gingko nuts", Epilepsia, 42, pp.280~281 (2001)
  96. Mock DM, "Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants", Neurology, 49, pp.1444~1447 (1997)
  97. Mock DM, "Disturbances in biotin metabolism in children undergoing long-term anticonvulsant therapy", J Pediatr Gastroenterol Nutr, 26, pp.245~250 (1998)
  98. Monaco F, "Free amino acids in serum of patients with epilepsy: significant increase in taurine", Epilepsia, 16, pp.245~249 (1975)
  99. Monami M, "Seizures as the only clinical manifestation of reactive hypoglycemia: a case report", J Endocrinol Invest, 28, pp.940~941 (2005)
  100. Mutani R, "Levels of free amino acids in serum and cerebrospinal fluid after administration of taurine to epileptic and normal subjects", Epilepsia, 16, pp.765~769 (1975)
  101. Nabbout R, "Pyridoxine dependent epilepsy: a suggestive electroclinical pattern", Arch Dis Child Fetal Neonatal Ed, 81, pp.F125~F129 (1999)
  102. Nicolai J, "Folinic acid-responsive seizures initially responsive to pyridoxine", Pediatr Neurol, 34, pp.164~167 (2006)
  103. Nuytten D, "Magnesium deficiency as a cause of acute intractable seizures", J Neurol, 238, pp.262~264 (1991)
  104. Ogunmekan AO, "A randomized, doubleblind, placebo-controlled, clinical trial of d-alphatocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children", Epilepsia, 30, pp.84~89 (1989)
  105. Ogunmekan AO, "Vitamin E deficiency and seizures in animals and man", Can J Neurol Sci, 6, pp.43~45 (1979)
  106. Pack AM, "Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications", CNS Drugs, 15, pp.633~642 (2001)
  107. Peled N, "Melatonin effect on seizures in children with severe neurologic deficit disorders", Epilepsia, 42, pp.1208~1210 (2001)
  108. Pennetta R, "Electroclinical evaluation of the anti-epileptic action of taurine", Acta Neurol (Napoli), 32, pp.316~322 (1977)
  109. Peterson P, "Calcium balance in drug-induced osteomalacia: response to vitamin D", Clin Pharmacol Ther, 19, pp.63~67 (1976)
  110. Pfeiffer CC, "Zinc and manganese in the schizophrenias", J Orthomolecular Psychiatry, 12, pp.215~234 (1983)
  111. Raju GB, "Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy", Epilepsia, 35, pp.368~372 (1994)
  112. Ralston AJ, "Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants", Lancet, 295, pp.867~868 (1970)
  113. Reichelt KL, "Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion", J Appl Nutr, 42, pp.1~11 (1990)
  114. Reynolds EH, "Folate metabolism in epileptic and psychiatric patients", J Neurol Neurosurg Psychiatry, 34, pp.726~732 (1971)
  115. Roach ES, "N,N-dimethylglycine for epilepsy", N Engl J Med, 307, pp.1081~1082 (1982)
  116. Roach ES, "Failure of N,N-dimethylglycine in epilepsy", Ann Neurol, 14, pp.347~ (1983)
  117. Roberts HJ, "Aspartame and headache", Neurology, 45, pp.1631~ (1995)
  118. Said HM, "Biotin transport in the human intestine: inhibition by anticonvulsant drugs", Am J Clin Nutr, 49, pp.127~131 (1989)
  119. Schlanger S, "Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients", Epilepsia, 43, pp.103~104 (2002)
  120. Sheldon SH, "Pro-convulsant effects of oral melatonin in neurologically disabled children", Lancet, 351, pp.1254~ (1998)
  121. Shovic A, "‘We think your son has Lennox-Gastaut syndrome'-a case study of monosodium glutamate's possible effect on a child", J Am Diet Assoc, 97, pp.793~794 (1997)
  122. Silver J, "Letter: Vitamin D therapy for children on anticonvulsants", N Engl J Med, 293, pp.1106~ (1975)
  123. Snaith RP, "Serum folate and vitamin B12 in epileptics with and without mental illness", Br J Psychiatry, 116, pp.179~183 (1970)
  124. Steidl L, "Metabolism of magnesium and zinc in patients treated with antiepileptic drugs and with magnesium lactate", Magnesium, 6, pp.284~295 (1987)
  125. Sullivan C, "Seizures and natural vitamin E", Med J Aust, 152, pp.613~614 (1990)
  126. Tallian KB, "Role of the ketogenic diet in children with intractable seizures", Ann Pharmacother, 32, pp.349~361 (1998)
  127. Tamai H, "Alphatocopherol and fatty acid levels in red blood cells in patients treated with antiepileptic drugs", J Nutr Sci Vitaminol (Tokyo), 34, pp.627~631 (1988)
  128. Torres OA, "Folinic acid-responsive neonatal seizures", J Child Neurol, 14, pp.529~532 (1999)
  129. Trauner DA, "Medium-chain triglyceride (MCT) diet in intractable seizure disorders", Neurology, 35, pp.237~238 (1985)
  130. Trimble MR, "Folic acid and mental symptoms in children with epilepsy", J Neurol Neurosurg Psychiatry, 43, pp.1030~1034 (1980)
  131. Turner TL, "Magnesium therapy in neonatal tetany", Lancet, 1, pp.283~284 (1977)
  132. Tyagi A, "Herbal remedies, dietary supplements and seizures", Epilepsia, 44, pp.228~235 (2003)
  133. Vaddadi KS, "A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients", Psychopharmacology (Berl), 88, pp.362~367 (1986)
  134. Vaddadi KS, "The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia", Prostaglandins Med, 6, pp.375~379 (1981)
  135. Van Gelder NM, "Biochemical observations following administration of taurine to patients with epilepsy", Brain Res, 94, pp.297~306 (1975)
  136. Verrotti A, "Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs", Int J Clin Lab Res, 29, pp.36~40 (1999)
  137. Vining EP, "Clinical efficacy of the ketogenic diet", Epilepsy Res, 37, pp.181~190 (1999)
  138. Volpe SL, "Nutrient intake of children with intractable epilepsy compared with healthy children", J Am Diet Assoc, 107, pp.1014~1018 (2007)
  139. Walton RG, "Seizure and mania after high intake of aspartame", Psychosomatics, 27, pp.218~220 (1986)
  140. Wolf P, "Possibilities of non-pharmacological conservative treatment of epilepsy", Seizure, 8, pp.45~52 (1999)
  141. Wurtman RJ, "Aspartame: possible effect on seizure susceptibility", Lancet, 2, pp.1060~ (1985)
  142. Yuen AW, "Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial", Epilepsy Behav, 7, pp.253~258 (2005)

관련 논문AI추천

Efficacy of and Patient Compliance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-AnalysisFang Ye, Hong-Bin Sun, Jie Liu, Wan-Lin Jiang, Xiao-Jia Li대한신경과학회 · Journal of Clinical Neurology2015 · 제11권 제1호The Early Response to Dietary Therapy can Predict the Late Outcome in Children with Intractable Epilepsy고태성, 김민지, 안현지, 염미선, 임수영, 장한나대한신경과학회 · Journal of Clinical Neurology2021 · 제17권 제1호Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with EpilepsyBaki Arpacı, Betül Tekin Güveli, Dilek Ataklı, Duygu Aksoy, Hüseyin Sarı, Pelin Doğan Ak대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment김건하, 김미경, 백정현, 서영호, 은백린연세대학교의과대학 · Yonsei Medical Journal2014 · 제55권 제2호Anticonvulsant potential of some medicinal plants and their beneficial propertiesMohammad Asif셀메드 세포교정의약학회 · 셀메드2013 · 제3권 제4호Anticonvulsant potential of some traditional medicinal plantsMohammad Asif셀메드 세포교정의약학회 · 셀메드2014 · 제4권 제1호

이 간행물의 다른 논문 (6건)

Zingiber officinale Rosc.: A traditional herb with medicinal propertiesArshiya Sultana, Shahid Shah Chaudhary, Mohd Tariq, Shaikh Imtiyaz, Khaleequr Rahmanpp. 26-26Anticonvulsant potential of some medicinal plants and their beneficial propertiesMohammad Asifpp. 27-27A better understanding of traditional uses of Careya arborea Roxb.: Phytochemical and pharmacological reviewVidhu Aeri, Nupur Ambardarpp. 28-28Eruptive xanthomas: Might be traditional hawthorn vinegar induced?Müzeyyen Gönül, Seray Külcü Çakmak, Esra Özhamampp. 30-30Traditional medicines for common dermatological disorders in MauritiusMohamad Fawzi Mahomoodally, Ziad Dil Hossainpp. 31-31
원문 보기